)
)
Jiangsu Hengrui Medicine Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Jiangsu Hengrui Medicine
Access all reports
Jiangsu Hengrui Medicine Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of medicines. The company focuses on oncology, anesthesiology, endocrinology, and cardiovascular treatments, among other therapeutic areas. Hengrui Medicine develops innovative drugs and generics, aiming to meet diverse medical needs and enhance patient care. The company is headquartered in Lianyungang, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
600276
Country
🇨🇳 China